ArticleTherapeutic advances in medical oncology2021

Efficacy and safety of trifluridine/tipiracil plus bevacizumab and trifluridine/tipiracil or regorafenib monotherapy for chemorefractory metastatic colorectal cancer: a retrospective study.

Keigo Chida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.